Control of nuclear thyroid hormone signaling by cell surface proteins
Control of nuclear thyroid hormone signaling by cell surface proteins
批准号:
7572324
负责人:
Daniel Richard Buchholz
金额:
$7.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2011-04-30
关键词:
Activated LymphocyteAdultAdverse effectsAffectAmericanAmino Acid TransporterBindingBiological MetamorphosisBloodCardiovascular DiseasesCell NucleusCell Surface ProteinsCell membraneCellsCharacteristicsChemicalsCommunitiesComplementCytoplasmic ProteinDataDevelopmentDiseaseDoseDoxycyclineDrug Delivery SystemsEyeGene ExpressionGene Expression RegulationGoalsGrowth and Development functionIn VitroInterventionKnowledgeMalignant NeoplasmsMeasuresMetabolic DiseasesMetabolismMolecularNuclearObesityPharmacologic SubstanceProcessProductionRanaReporterResearchResearch PersonnelResourcesRoleSignal TransductionSiteSystemTadpolesTechnologyTestingTetracyclinesThyroid DiseasesThyroid Hormone ReceptorThyroid HormonesTissuesTransgenesTransgenic AnimalsTransgenic OrganismsWaterWorkXenopus laevisdesigndrug developmentimprovedin vivoinsightmeetingsoverexpressionprotein expressionresponsetransgene expression
中文摘要
描述(由申请人提供):甲状腺疾病影响超过2500万美国人,构成第二大最常见的代谢紊乱。 甲状腺激素(TH)对生长、发育和代谢至关重要,并通过结合细胞核中的TH受体和改变基因表达而起作用。 重要的是,TH必须从血液中穿过质膜以结合细胞核中的TH受体。 在这个易位过程中的一个细胞表面蛋白,L-型氨基酸转运蛋白LAT 1,强烈上调TH依赖的发展。 有趣的是,LAT 1表达也与快速分裂的细胞有关,如活化的淋巴细胞和癌症。 尽管已经进行了许多关于LAT 1功能的体外研究,但对LAT 1的体内发育作用还没有很好的了解。 本项目的目的是研究LAT 1在发育过程中如何调节组织对TH的反应。 这个项目补充了研究者的长期目标,阐明细胞质蛋白控制TH信号的分子机制。 为了实现这一目标,计划是,在具体目标1,开发和表征改进的四环素诱导的转基因系统。 他将设计,生产和表征转基因诱导剂和报告品系,当杂交时,将能够高水平的转基因诱导。 这种改进的系统将使我们能够最大限度地减少泄漏的转基因表达,减少由插入位点引起的转基因表达水平的变异性,以及用以不同剂量施用的诱导性化学多西环素(Dox)“拨入”转基因表达水平。 此外,该系统可以扩展以实现组织特异性转基因诱导。 初步数据显示在不存在Dox的情况下最小的泄漏表达和在存在Dox的情况下的高转基因诱导。 具体目标2然后将检查在TH依赖性发展的体内作用的LAT 1。 研究者将使用目标1的转基因技术来检验LAT 1在体内调节TH信号传导的假设。 他将比较TH诱导的形态学和基因调控变化的速率和幅度,在用和不用Dox诱导LAT 1过表达的转基因蝌蚪中进行。 该项目有望揭示关于LAT 1如何在体内调节TH信号的基本见解。 特别地,预期TH转运蛋白LAT 1的过表达将增加TH对核TH受体的可用性,如通过增加的TH依赖性基因表达和形态学变化所测量的。 该项目的一个显著的积极影响是,研究人员将扩展一个完善的系统的有用性,用于研究TH依赖的发展,青蛙变态,并提供新的转基因资源的青蛙社区。 这些资源将对各种各样的实验方法有用。 此外,当考虑将LAT 1作为治疗甲状腺疾病和癌症的药物开发靶点时,了解LAT 1如何在体内调节组织对TH的反应是重要的。
项目叙述:研究人员正在研究细胞表面蛋白LAT 1如何影响发育过程中的甲状腺激素信号传导。 重要的是,LAT 1已被确定为治疗甲状腺疾病和相关疾病和并发症(如肥胖症、心血管疾病和癌症)的药物靶标。 因此,当考虑使用靶向LAT 1的药物来评估潜在的益处和副作用时,LAT 1的发育作用的知识是重要的。
英文摘要
DESCRIPTION (provided by applicant): Thyroid diseases affect over 25 million Americans and constitute the second most common group of metabolic disorders. Thyroid hormone (TH) is critical for growth, development, and metabolism, and works by binding TH receptors in the cell nucleus and changing gene expression. Importantly, TH must cross the plasma membrane from the blood to bind TH receptors in the nucleus. One cell surface protein in this translocation process, the L-type amino acid transporter LAT1, is strongly up-regulated during TH-dependent development. Interestingly, LAT1 expression is also associated with rapidly dividing cells, such as activated lymphocytes and cancer. Even though many in vitro studies on LAT1 function have been carried out, the in-vivo developmental role of LAT1 is not well understood. The objective of the current project is to study how LAT1 regulates tissue responses to TH during development. This project complements the investigator's long-term goal of elucidating molecular mechanisms underlying control of TH signaling by cytoplasmic proteins. To achieve this objective, the plan is to, in Specific Aim 1, develop and characterize an improved tetracycline-inducible transgenic system. He will design, produce, and characterize transgenic inducer and reporter lines that, when crossed, will be capable of high levels of transgene induction. This improved system will enable us to minimize leaky transgene expression, reduce variability in transgene expression levels caused by insertion sites, and "dial in" transgene expression levels with the inducing chemical doxycycline (Dox) administered at different doses. In addition, this system can expand to enable tissue-specific transgene induction. Preliminary data showed minimal leaky expression in the absence of Dox and high transgene induction in the presence of Dox. Specific Aim 2 will then examine the in-vivo role of LAT1 in TH-dependent development. The investigator will use the transgenic technology from Aim 1 to test the hypothesis that LAT1 modulates TH signaling in vivo. He will compare rate and magnitude of TH-induced morphological and gene regulation changes in transgenic tadpoles treated with and without Dox to induce LAT1 overexpression. This project is expected to reveal fundamental insights about how LAT1 regulates TH signaling in vivo. In particular, it is expected that overexpression of the TH transporter LAT1 will increase availability of TH to nuclear TH receptors as measured by increased TH-dependent gene expression and morphological change. A significant positive impact of this project is that the investigator will extend the usefulness of a well-established system for studying TH-dependent development, frog metamorphosis, and provide new transgenic resources to the frog community. These resources will be useful for a wide variety of experimental approaches. In addition, knowledge of how LAT1 regulates tissue responses to TH in-vivo is significant when considering LAT1 as a target for drug development in the treatment of thyroid disorders and cancer.
PROJECT NARRATIVE: The investigator is studying how the cell surface protein LAT1 affects thyroid hormone signaling during development. Importantly, LAT1 has been identified as a drug target in the treatment of thyroid diseases and related disorders and complications, such as obesity, cardiovascular disease, and cancer. Thus, knowledge of developmental roles of LAT1 is important when considering use of drugs targeting LAT1 to evaluate potential benefits and side-effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of nuclear thyroid hormone signaling by cell surface proteins
-
批准号:7817030
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2009
-
负责人:Daniel Richard Buchholz
-
依托单位:
THYROID HORMONE RECEPTORS IN FROG METAMORPHOSIS
-
批准号:6634814
-
项目类别:
-
资助金额:$4.7万
-
财政年份:2002
-
负责人:Daniel Richard Buchholz
-
依托单位:
THYROID HORMONE RECEPTORS IN FROG METAMORPHOSIS
-
批准号:6516934
-
项目类别:
-
资助金额:$4.31万
-
财政年份:2002
-
负责人:Daniel Richard Buchholz
-
依托单位:
THYROID HORMONE RECEPTORS IN FROG METAMORPHOSIS
-
批准号:6136299
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2001
-
负责人:Daniel Richard Buchholz
-
依托单位:
海外基金